ClinicalTrials.gg
Sign In

Epilepsies, Myoclonic clinical trials

The registry lists 92 studies for Epilepsies, Myoclonic across more than 10 countries. 21 are recruiting or about to start. 71 of them are mainly about Epilepsies, Myoclonic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-02.

Get an email when these change. Save the Epilepsies, Myoclonic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
32
Recruiting
14
Terminated
12
Active, not recruiting
10
Withdrawn
6
No longer available
4

Phase

Phase 3
25
Phase 2
18
Phase 1
13
Phase 4
5
Early Phase 1
1

Where

United States
61
Canada
18
Spain
18
France
18
Australia
17
Italy
17

Who runs them

Takeda (7) · Jazz Pharmaceuticals (7) · Longboard Pharmaceuticals (5) · Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. (5) · Encoded Therapeutics (4) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (3) · Gillette Children's Specialty Healthcare (3) · University of Colorado, Denver (3)

What is being tested here

Drugs under test in Epilepsies, Myoclonic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Fenfluramine2711
Cannabidiol1814
Bexicaserin124
ETX101103
Clemizole hydrochloride112
Glycerol phenylbutyrate101
BMB-101101
Soticlestat035
Zorevunersen013
Cysteamine002

Drug classes tested here Serotonin receptor agonists 1 open

Coming up

4phase 3 studies under way
11studies finish main data collection within a year4 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 14 Epilepsies, Myoclonic studies recruiting now, 3 (21%) set no upper age limit and 10 (71%) stop at 75 or younger. 11 (79%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (21%) take healthy volunteers.

Recruiting studies that take each age, of 14
AgeWomenMen
109 (64%)9 (64%)
1810 (71%)10 (71%)
307 (50%)7 (50%)
407 (50%)7 (50%)
507 (50%)7 (50%)
655 (36%)5 (36%)
754 (29%)4 (29%)
854 (29%)4 (29%)

Across all 92 studies, recruiting or not: 70% stop at 75 or younger and 67% at 65; 90% take children; 1% are for women only and 0% for men only; 12% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Epilepsies, Myoclonic studies take

Of 15 phase 3 interventional studies under Epilepsies, Myoclonic, half reached primary completion within 35 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 335 mo27–72 · 15 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 92. Browse all 92 → or search them.